Navigation Links
Tiny radioactive spheres effectively treat cancer that has spread to the liver
Date:10/29/2007

JACKSONVILLE, Fla. − Placing tiny radioactive spheres directly into the liver through its blood supply halted growth of tumors that had spread to the organ in 71 percent of patients tested in a small clinical trial, researchers from Mayo Clinic Jacksonville report.

They say that the technique appears to offer a treatment option for patients who develop multiple tumors in their liver from cancer metastasis.

Most of these patients dont have other effective treatment options, because surgery is not possible if there are multiple tumors in their liver, says the studys lead investigator, Laura Vallow, M.D. But with this radiotherapy, no new tumors developed in patients who responded and we find this to be very encouraging.

Vallow presented results of the study at the annual meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO).

She says her report is one of the first to sum up an initial clinical experience with the therapy, known as SIR-Spheres microspheres, which was approved for use by the federal Food and Drug Administration in 2002. We are trying to determine the clinical situations in which it is best to use these microspheres, Vallow says.

The therapy uses millions of tiny polymer beads − each one of which is about one-third the diameter of a human hair − which contain the radioactive element yttrium-90. An interventional radiologist uses a catheter to infuse the microspheres directly into the hepatic artery, which supplies all the blood to the liver. There the beads deliver radiation directly to tumors for about 11 days.

In this study, data from 20 patient procedures using microspheres at Mayo Clinic Jacksonville were analyzed. The entire liver was treated in 75 percent of the cases, and in the remaining 25 percent, either the left or right lobe of the liver was selectively targeted. Four weeks after treatment, researchers used CT scans to assess response of tumors, and found that in 71 percent, tumors decreased in size. The tumors were smaller or less active with less contrast uptake on follow-up CT scans, Vallow says.

The majority of patients had minimal side effects from the treatment, she says. Cancer progressed in two patients and they died within three months. But for the patients who responded, by the end of a 10-month follow-up period, no new tumors were detected, Vallow says. Liver function tests in the responding patients have become normal or have stabilized.

The researchers say the treatment works best in patients that have good blood flow to their tumors. Further evaluation with longer follow-up will help clarify the benefit of this novel treatment, Vallow says.


'/>"/>
Contact: Kevin Punsky
punsky.kevin@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
2. Bacteria Commonly Seen In Radioactive Waste, Hot Springs Found Inside Humans
3. Brain Cancer Could be Safely Treated with Radioactive Scorpion Venom
4. Chornobyl Incident Proved Increased Risk of Thyroid Cancer from Radioactive Iodine
5. Adult COPD or asthma could be effectively treated with Xopenex
6. CPR! How Effectively is it being done ?
7. Using Cholesterol Lowering Drugs Effectively
8. Older Breast Cancer Patients Can Be Effectively Treated With Chemotherapy
9. Fungal Infections Effectively Controlled By Light Therapy
10. Elderly People Needs To Tackle The Heat Effectively
11. Treating Autism More Effectively
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Columbus, Ohio (PRWEB) , ... March 28, 2017 , ... ... City was selected as one of few medical professionals in the country to sit ... As Founder of Juvly Aesthetics, in just 2 years Dr. Harper helped propel the ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... ... Carson Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently ... balloon procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive ...
(Date:3/28/2017)... GA (PRWEB) , ... March 28, 2017 , ... With ... to Marshallville, Georgia, in early March. , The seed processing plant opened in Marshallville ... location since 2016. The new office allows opportunity for transition of Patten Seed operations ...
(Date:3/28/2017)... ... March 28, 2017 , ... Thank you to all who ... 8-10. , This event was exclusive to providers and offered an opportunity to ... took place at the Manchester Grand Hyatt where attendees gathered for a lively discussion ...
(Date:3/28/2017)... ... March 28, 2017 , ... Bacteria and fungi are probably not the first ingredients that ... fact, including the right microorganisms in your diet can actually improve health outcomes. And the ... This is the topic of a new peer-reviewed paper led by Maria ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Summary This report provides all the information ... and activities since 2010. Description The Partnering Deals and ... partnering activity of one of the world,s leading life sciences ... purchase to ensure inclusion of the most up to date ... delivered in PDF format within 1 working day of receipt ...
(Date:3/27/2017)... -- Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or the "Company") ... common stock in an underwritten public offering under an ... and Exchange Commission (the "SEC"). The offering is subject ... no assurance as to whether or when the offering ... or terms of the offering. Cryoport also expects to ...
(Date:3/27/2017)... , March 27, 2017  A new ... (AADE) found that Medicare,s Competitive Bidding Program (CBP) significantly ... testing supplies. The lack of choice forces beneficiaries to ... have dire health consequences. AADE,s survey ... by AADE and others pointing out the inherent problems ...
Breaking Medicine Technology: